CSL Limited (ASX:CSL) Declares Dividend Increase – $2.20 Per Share

CSL Limited (ASX:CSL) declared a final dividend on Thursday, September 5th, MarketIndexAU reports. Stockholders of record on Tuesday, October 1st will be given a dividend of 2.203 per share on Tuesday, October 1st. This represents a dividend yield of 0.73%. The ex-dividend date is Sunday, September 8th. This is an increase from CSL’s previous final dividend of $1.99.

CSL Price Performance

The company has a current ratio of 2.17, a quick ratio of 1.68 and a debt-to-equity ratio of 62.80.

Insiders Place Their Bets

In other news, insider Paul McKenzie acquired 8,275 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was bought at an average cost of A$306.03 ($208.18) per share, with a total value of A$2,532,398.25 ($1,722,719.90). In related news, insider Paul McKenzie purchased 8,275 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average price of A$306.03 ($208.18) per share, for a total transaction of A$2,532,398.25 ($1,722,719.90). Also, insider Carolyn Hewson acquired 193 shares of CSL stock in a transaction on Friday, August 16th. The shares were bought at an average price of A$305.34 ($207.71) per share, for a total transaction of A$58,930.04 ($40,088.46). 0.30% of the stock is owned by company insiders.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.